Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder
- 1 July 2007
- journal article
- review article
- Published by SAGE Publications in Autism
- Vol. 11 (4), 335-348
- https://doi.org/10.1177/1362361307078132
Abstract
The variable expression of autism over the lifespan is likely to lead to different symptoms and support requirements, and to distinct responses to pharmacotherapy treatment, in older patients compared to children. This systematic review considers the effectiveness of pharmacological treatment in managing autism spectrum disorder in adolescents and adults. Following a comprehensive search of literature published in English from 1980, methodological criteria were applied to identify studies designed to reliably assess treatment effectiveness. Only five double-blind, randomized controlled trials were eligible for appraisal. All had small sample sizes (mean = 30) and brief treatment duration of no more than 12 weeks. The paucity of trials and their methodological limitations means that there is only preliminary evidence about the short-term effectiveness of a few drug treatments for this age group. There was also a lack of reliable data reported on drug safety profiles. Methodological challenges and directions for future research are discussed.Keywords
This publication has 25 references indexed in Scilit:
- Combined vitamin B6-magnesium treatment in autism spectrum disorderCochrane Database of Systematic Reviews, 2005
- Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trialsResearch in Developmental Disabilities, 2005
- Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North CarolinaJournal of Child and Adolescent Psychopharmacology, 2002
- Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with AutismJournal of Child and Adolescent Psychopharmacology, 2001
- Pharmacotherapeutic management of autismExpert Opinion on Pharmacotherapy, 2001
- Effects of Risperidone on Aberrant Behavior of Persons With Developmental Disabilities: I. A Double-Blind Crossover Study Using Multiple MeasuresAmerican Journal on Mental Retardation, 2001
- AutismNew England Journal of Medicine, 1997
- A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic DisorderArchives of General Psychiatry, 1996
- Autistic Children as Adults: Psychiatric, Social, and Behavioral OutcomesJournal of the American Academy of Child Psychiatry, 1985
- COGNITIVE DEFICITS IN THE PATHOGENESIS OF AUTISM*Journal of Child Psychology and Psychiatry, 1983